$851 Million is the total value of CLOUGH CAPITAL PARTNERS L P's 145 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | $9,197,000 | -1.0% | 210,700 | 0.0% | 1.08% | +23.4% | |
| GWRE | GUIDEWIRE SOFTWARE INC | $6,450,000 | -20.6% | 80,400 | 0.0% | 0.76% | -1.0% | |
| CHCT | COMMUNITY HEALTHCARE TR INC | $6,265,000 | -6.9% | 217,300 | 0.0% | 0.74% | +15.9% | |
| KURA | KURA ONCOLOGY INC | $1,127,000 | -19.8% | 80,261 | 0.0% | 0.13% | -0.8% | |
| CAF | MORGAN STANLEY CHINA A SH FD | $1,092,000 | -15.0% | 59,800 | 0.0% | 0.13% | +5.8% | |
| ASHR | DBX ETF TRxtrack hrvst csi | $989,000 | -13.5% | 45,100 | 0.0% | 0.12% | +7.4% | |
| POOL | POOL CORPORATION | $595,000 | -10.9% | 4,000 | 0.0% | 0.07% | +11.1% | |
| JRO | NUVEEN FLTNG RTE INCM OPP FD | $143,000 | -12.3% | 15,803 | 0.0% | 0.02% | +13.3% | |
| CWSA | CITIGROUP INCw exp 01/04/201 | $0 | – | 271,800 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Charles I. Clough, Jr. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 37 | Q3 2023 | 5.0% |
| MICROSOFT CORP | 35 | Q3 2023 | 5.5% |
| CITIGROUP INC | 33 | Q2 2021 | 5.8% |
| JPMORGAN CHASE & CO | 33 | Q3 2023 | 3.2% |
| D R HORTON INC | 32 | Q3 2023 | 3.2% |
| TRANSDIGM GROUP INC | 32 | Q3 2023 | 3.9% |
| VERTEX PHARMACEUTICALS INC | 32 | Q2 2023 | 1.6% |
| JAZZ PHARMACEUTICALS PLC | 32 | Q3 2023 | 1.6% |
| VERACYTE INC | 31 | Q2 2023 | 0.8% |
| LENNAR CORP | 30 | Q1 2022 | 2.7% |
View CLOUGH CAPITAL PARTNERS L P's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. | February 14, 2022 | 1,137,764 | 5.3% |
| Correvio Pharma Corp.Sold out | February 24, 2020 | 0 | 0.0% |
| Cardiome Pharma Corp | April 27, 2018 | 2,058,763 | 5.9% |
| CARVANA CO. | April 27, 2018 | 1,072,050 | 3.6% |
| HEALTHWAYS, INC | January 12, 2016 | 1,850,289 | 5.1% |
| Kura Oncology, Inc. | January 12, 2016 | 1,076,333 | 5.0% |
| VERACYTE, INC. | January 12, 2016 | 1,049,054 | 3.8% |
| Solar Senior Capital Ltd. | February 11, 2013 | 325,093 | 2.8% |
| MAGAL SECURITY SYSTEMS LTDSold out | March 23, 2011 | 0 | 0.0% |
| BIOSPHERE MEDICAL INCSold out | February 10, 2011 | 0 | 0.0% |
View CLOUGH CAPITAL PARTNERS L P's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View CLOUGH CAPITAL PARTNERS L P's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.